Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0000899243-21-013283

President and CEO sold 16,700 shares at an average $68.49 ($1,143,860)

  • President and CEO acquired 16,700 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pons Jaume · President and CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-22 Exercise or conversion : show line 1 in the form +16,700 $1.91 $31,897 568,046 D
2021-03-22 Sale : show line 2 in the form −1,200 $63.79 $76,545 566,846 D
2021-03-22 Sale : show line 3 in the form −900 $64.98 $58,486 565,946 D
2021-03-22 Sale : show line 4 in the form −600 $66.33 $39,795 565,346 D
2021-03-22 Sale : show line 5 in the form −1,500 $67.18 $100,773 563,846 D
2021-03-22 Sale : show line 6 in the form −2,700 $68.27 $184,329 561,146 D
2021-03-22 Sale : show line 7 in the form −9,200 $69.77 $641,857 551,946 D
2021-03-22 Sale : show line 8 in the form −600 $70.12 $42,075 551,346 D
Open-market sales · 16,700 sh · avg $68.49 · $1,143,860

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-22 Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) −16,700 89,019 D
Loading xslF345X03/doc4.xml…